4.5 Article

Association of Alzheimer's disease GWAS loci with MRI markers of brain aging

Journal

NEUROBIOLOGY OF AGING
Volume 36, Issue 4, Pages -

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.neurobiolaging.2014.12.028

Keywords

Alzheimer; MRI-Markers; Genetic risk score; GWAS; Hippocampal volume

Funding

  1. NIA [N01-AG-12100]
  2. NEI
  3. NIDCD
  4. NHLBI
  5. NIA Intramural Research Program, Hjartavernd (the Icelandic Heart Association)
  6. Althingi (the Icelandic Parliament)
  7. National Heart, Lung, and Blood Institute [HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, HHSN268201100012C, R01HL087641, R01HL59367, R01HL086694, R01HL7825]
  8. National Human Genome Research Institute [U01HG004402]
  9. National Institutes of Health [HHSN268200625226C, R01 AG040039, R21 NS076827, P20 MD006886]
  10. NIH Roadmap for Medical Research
  11. NHLBI [HHSN268201200036C, HHSN268200800007C, N01HC55222, N01HC85079, N01HC85080, N01HC85081, N01HC85082, N01HC85083, N01HC85086, N01HC15103, U01HL080295, R01HL087652, R01HL105756, R01HL103612, R01HL120393]
  12. National Institute of Neurological Disorders and Stroke (NINDS)
  13. Austrian Science Fond (FWF) [P20545-P05, P13180]
  14. Medical University of Graz
  15. Framingham Heart Study's National Heart, Lung, and Blood Institute [N01-HC-25195]
  16. Affymetrix, Inc for genotyping services [N02-HL-6-4278]
  17. Robert Dawson Evans Endowment of the Department of Medicine at Boston University School of Medicine and Boston Medical Center
  18. National Institute on Aging [R01 AG08122, AG033193, P30 AG0101029, P30AG10161, R01AG17917, R01AG15819]
  19. National Institute of Neurological Disorders and Stroke [R01 NS17950]
  20. Illinois Department of Public Health
  21. Netherlands Organization of Scientific Research NWO [175.010.2005.011]
  22. Netherlands Genomics Initiative (NGI)/Netherlands Organisation for Scientific Research (NWO) [050-060-810]
  23. Erasmus Medical Center and Erasmus University, Rotterdam
  24. Netherlands Organization for Scientific Research (NWO)
  25. Netherlands Organization for the Health Research and Development (ZonMw) [916.13.054]
  26. Research Institute for Diseases in the Elderly (RIDE)
  27. Ministry of Education, Culture and Science
  28. Ministry for Health, Welfare and Sports
  29. European Commission (DG XII)
  30. Municipality of Rotterdam
  31. Internationale Stichting Alzheimer Onderzoek
  32. National Health and Medical Research Council (NHMRC) [403000, 491109, 606543]
  33. Wicking Dementia Education and Research Centre, Hobart
  34. NHMRC/National Heart Foundation Career Development Fellowship [606544]
  35. Fondation pour la Recherche Medicale
  36. Caisse Nationale Maladie des Travailleurs Salaries
  37. Direction Generale de la Sante
  38. Mutuelle Generale de l'Education Nationale (MGEN)
  39. Institut de la Longevite
  40. Conseils Regionaux of Aquitaine and Bourgogne
  41. Fondation de France
  42. Ministry of Research-INSERM Programme Cohortes et collections de donnees biologiques
  43. Eisai
  44. National Foundation for Alzheimer's Disease and Related Disorders
  45. Institut Pasteur de Lille
  46. Centre National de Genotypage
  47. Fondation Leducq
  48. Agence Nationale de la Recherche (Chaire d'Excellence)
  49. [UL1RR025005]
  50. [HL093029]
  51. Austrian Science Fund (FWF) [P13180] Funding Source: Austrian Science Fund (FWF)

Ask authors/readers for more resources

Whether novel risk variants of Alzheimer's disease (AD) identified through genome-wide association studies also influence magnetic resonance imaging-based intermediate phenotypes of AD in the general population is unclear. We studied association of 24 AD risk loci with intracranial volume, total brain volume, hippocampal volume (HV), white matter hyperintensity burden, and brain infarcts in a meta-analysis of genetic association studies from large population-based samples (N = 8175-11,550). In single-SNP based tests, AD risk allele of APOE (rs2075650) was associated with smaller HV (p = 0.0054) and CD33 (rs3865444) with smaller intracranial volume (p = 0.0058). In gene-based tests, there was associations of HLA-DRB1 with total brain volume (p = 0.0006) and BIN1 with HV (p = 0.00089). A weighted AD genetic risk score was associated with smaller HV (beta +/- SE = -0.047 +/- 0.013, p = 0.00041), even after excluding the APOE locus (p = 0.029). However, only association of AD genetic risk score with HV, including APOE, was significant after multiple testing correction (including number of independent phenotypes tested). These results suggest that novel AD genetic risk variants may contribute to structural brain aging in nondemented older community persons. (C) 2015 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available